top of page
Blurry Blue

Clinical Trial Screening

Built for Cancer Care Providers and Life Sciences Sponsors

Homepage.png
timeline.png
Frame 11.png
Group 21.png
Frame 13.png
Frame 14.png

Trial Enrollment

PRISM
Prism supports clinical trial enrollment by matching patients to trials or trials to patients.
Blurry Blue
PRISM

Trial Enrollment

Mockup text for our product PRISM Mockup text for our product PRISM

timeline.png
Frame 11.png
Group 21.png
Frame 13.png
TRIAL ENROLMENT.png
Frame 14.png

THE PROBLEM

Oncologists and their staff are collectively responsible for matching thousands of patients to hundreds of clinical trials each year. This complex, computationally intensive task is ideally suited for artificial intelligence (AI), yet the methodologies have not changed for decades. Due to the lack of a scalable process for clinicians and their staff to match patients with trials, the task often requires manual chart reviews. Consequently, some patients fall through the cracks and miss out on potentially life-altering treatments.

Oncologists and clinical trial coordinators must match 1,000s of patients to 100s of clinical trials.

The Problem

  • Oncologists and their staff are collectively responsible for matching thousands of patients to hundreds of clinical trials each year. This complex, computationally intensive task is ideally suited for artificial intelligence (AI), yet the methodologies have not changed for decades

  • Due to the lack of a scalable process for clinicians and their staff to match patients with trials, the task often requires manual chart reviews

  • Consequently, some patients fall through the cracks and miss out on potentially life-altering treatments, while studies take longer to reach their enrollment targets.

The Problem

Oncologists must match thousands of patients to clinical trials annually.

Trial-matching methods remain outdated despite AI’s potential.

Manual chart reviews persist due to a lack of scalable processes.

As a result, some patients miss critical treatment opportunities.

UNDERSTANDING PRISM

Watch our VP of Clinical Data, Regina Schwind, as she introduces Prism, our trial enrollment solution, and explains how we collaborate with various organizations.

How it works

Powered by OncoLLM, Prism can manage various approaches and challenges related to clinical trial enrollment. The platform is designed to help match patients with trials and vice versa, among other capabilities:

1. Patient-to-Trial Matching

Screen patients with upcoming appointments for all locally ongoing trials.

ONCOLLM.png
ONCOLLM.png
Group 104.png
Group 103.png
Frame 427320596.png
Frame 16.png
Frame 15.png
Frame 14.png
Frame 13.png
Trial Info.png
xc.png
c.png
zx.png
cxxxx.png
x xx.png

2. Trial-to-Patient Matching

Finds active patients eligible for an upcoming (feasibility) or ongoing trial.

3. Continuous Tracking

Automatically track currently ineligible patients for any future trial opportunities, for example, by automatically detecting disease progression.

Continuous Tracking: Automatically track unmatched patients for any future trial opportunities.
Frame 427320592.png
Group 107.png
Group 108.png
Group 106.png
Group 105.png

We designed our platform to be

01

Proactive

The system continually tracks upcoming or recent appointments and radiology results, and provides an in-basket notification to the clinician and study team when a match is found.

02

Comprehensive

Prism works across your entire portfolio, including federally funded, investigator-initiated, and industry-sponsored trials.

03

Compatible

We integrate with existing EHRs, including Epic, Cerner, OncoEMR and more, and are approved and available on Epic's app marketplace.

04

Scalable

Prism doesn't require complex, study-specific builds, letting you go-live with all your studies on Day 0.

05

Accurate

Our published data shows that our models provide expert level accuracy (NPJ Paper and ASCO Poster)

06

Accessible and Equitable

At-scale prescreening of patients from underserved communities enables research teams to meet their diversity enrollment targets, increasing cancer trial access and equity.

HOW IT WORKS

Powered by OncoLLM, Prism can manage various approaches and challenges related to clinical trial enrollment. The platform is designed to help match patients with trials and vice versa, among other capabilities:
Patient-to-Trial Matching

Screen patients with upcoming appointments for all locally ongoing trials.

Patient-to-Trial Matching: Screen patients with upcoming appointments for all locally ongoing trials.
Proactive

The system continually tracks upcoming or recent appointments and radiology results, and provides an in-basket notification to the clinician and study team when a match is found.

Compatible

We integrate with existing EHRs, including Epic, Cerner, OncoEMR and several others,and are approved and available on Epic's app marketplace.

Accurate

Our published data shows that our models outperform larger language models and traditional NLP solutions.

Comprehensive

Ability to utilize Prism across your entire portfolio, including federally funded, investigator initiated and sponsor led trials.

Scalable

Prism doesn't require complex, study-specific builds, letting you go-live with all your studies on Day 0

More Accessible and Equitable

At-scale pre-screening of patients from under-served communities enables the research teams to meet their diversity enrolment targets, increasing access and equity in cancer trials.

OUR SOLUTION

We designed our platform to be:

WE DESIGNED OUR PLATFORM TO BE

Proactive

The system continually tracks upcoming or recent appointments and radiology results, and provides an in-basket notification to the clinician and study team when a match is found.

Comprehensive

Prism works across your entire portfolio, including federally funded, investigator-initiated, and industry-sponsored trials.

Compatible

We integrate with existing EHRs, including Epic, Cerner, OncoEMR and more, and are approved and available on Epic's app marketplace.

Scalable

Prism doesn't require complex, study-specific builds, letting you go-live with all your studies on Day 0.

Accurate

Our published data shows that our models outperform larger language models and traditional NLP solutions. 

Accessible and Equitable

At-scale prescreening of patients from underserved communities enables research teams to meet their diversity enrollment targets, increasing cancer trial access and equity.

7,000

Patients Screened Monthly

Every patient visit, screened with 100% coverage, driving comprehensive trial matching.

>30%

Increase in Trial Accruals

Boosted enrollment across their clinical trial portfolio in Q3–Q4 2024 vs. 2023.

>70%

Faster Eligibility Screening

Significant reduction in time spent identifying qualified patients.

6 weeks

Rapid Go-Live

Full deployment, including setup of 100 oncology trials that took less than a week.

Our Results

We measured the performance of our platform in accurately identifying trials for patients at a cancer center with hundreds of ongoing oncology trials. Our system achieved an accuracy of over 95% in identifying the correct trial within its top three recommendations, accomplishing this in just minutes. You can learn more about our publication in Nature Digital Medicine at this link.

Life Sciences Sponsors

We’re already partnered with several leading life sciences sponsors to accelerate clinical trials through our platform, live at many of the top cancer centers. Here’s how we can help you:

Accelerate recruitment timelines

Shorten FPI and LPI milestones by reducing screening burden and enabling proactive site-level screening.

Access precise feasibility data

Identify sites and their counts of fully eligible patients, based on real-time EHR-integrated data.

Improve trial design

Uncover which eligibility criteria are overly restrictive and refine protocols accordingly.

Understanding Prism

OUR RESULTS

We measured the performance of our platform in accurately identifying trials for patients at a cancer center with hundreds of ongoing oncology trials. Our system achieved an accuracy of over 95% in identifying the correct trial within its top three recommendations, accomplishing this in just minutes. You can learn more at this link.

Prism achieved over 95% accuracy in identifying the correct clinical trial in its top 3 recommendations.

WHY PRISM

Trial sponsors benefit from recruitment of more patients, in less time, from larger and more diverse catchment areas. Plus, our process can be supported by an expert-led team of clinical navigators.

Trial sponsors benefit from recruitment of more patients, in less time, from larger and more diverse catchment areas. Plus, our process can be supported by an expert-led team of clinical navigators.

Image by National Cancer Institute

CONTACT US

partnerships@triomics.com

contact@triomics.com

888-ONCO-LLM

(888-662-6556)

1 World Trade Center, Ste. 46C

New York, NY 10007

Copyright 2024

About us

Our team of technologists and clinicians drives our values.

Browse our site to learn more, or contact us directly to see how we can work together.

bottom of page